Prelude Capital Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,800
| Closed | -$28.6K | – | 1458 |
|
|
2024
Q3 | $28.6K | Sell |
16,800
-2,286
| -12% | -$3.76K | ﹤0.01% | 1233 |
|
|
2024
Q2 | $26.1K | Buy |
19,086
+1,236
| +7% | +$2.5K | ﹤0.01% | 1170 |
|
|
2024
Q1 | $66.9K | Sell |
17,850
-2,309
| -11% | -$13.5K | ﹤0.01% | 1235 |
|
|
2023
Q4 | $198K | Buy |
+20,159
| New | +$165K | 0.01% | 945 |
|
|
2023
Q2 | – | Sell |
-21,677
| Closed | -$251K | – | 1297 |
|
|
2023
Q1 | $251K | Buy |
+21,677
| New | +$216K | 0.02% | 736 |
|
|
2022
Q4 | – | Sell |
-88,851
| Closed | -$516K | – | 1536 |
|
|
2022
Q3 | $516K | Buy |
+88,851
| New | +$510K | 0.02% | 633 |
|
|
2021
Q4 | – | Sell |
-22,000
| Closed | -$562K | – | 2183 |
|
|
2021
Q3 | $562K | Sell |
22,000
-41,300
| -65% | -$1.22M | 0.01% | 829 |
|
|
2021
Q2 | $2.21M | Buy |
63,300
+3,690
| +6% | +$107K | 0.07% | 266 |
|
|
2021
Q1 | $1.99M | Buy |
59,610
+37,610
| +171% | +$1.32M | 0.05% | 346 |
|
|
2020
Q4 | $571K | Buy |
22,000
+2,500
| +13% | +$42.5K | 0.01% | 680 |
|
|
2020
Q3 | $192K | Sell |
19,500
-2,500
| -11% | -$14.4K | 0.01% | 705 |
|
|
2020
Q2 | $76K | Buy |
+22,000
| New | +$74.9K | ﹤0.01% | 1033 |
|
|
2020
Q1 | – | Sell |
-162,525
| Closed | -$835K | – | 1879 |
|
|
2019
Q4 | $835K | Sell |
162,525
-26,669
| -14% | -$136K | 0.03% | 438 |
|
|
2019
Q3 | $976K | Buy |
189,194
+37,635
| +25% | +$210K | 0.04% | 339 |
|
|
2019
Q2 | $917K | Buy |
+151,559
| New | +$1.06M | 0.05% | 363 |
|
|
2019
Q1 | – | Sell |
-56,782
| Closed | -$420K | – | 2062 |
|
|
2018
Q4 | $420K | Buy |
56,782
+56,053
| +7,689% | +$355K | 0.03% | 519 |
|
|
2018
Q3 | $4K | Buy |
729
+29
| +4% | +$124 | ﹤0.01% | 1647 |
|
|
2018
Q2 | $2K | Buy |
+700
| New | +$1.94K | ﹤0.01% | 1600 |
|
|
2017
Q3 | – | Sell |
-15,311
| Closed | -$55K | – | 1832 |
|
|
2017
Q2 | $55K | Sell |
15,311
-203
| -1% | -$819 | 0.01% | 973 |
|
|
2017
Q1 | $80K | Buy |
15,514
+15,373
| +10,903% | +$75.2K | 0.01% | 863 |
|
|
2016
Q4 | $1K | Buy |
+141
| New | +$1.02K | ﹤0.01% | 1499 |
|
|
2016
Q2 | – | Sell |
-990
| Closed | -$8K | – | 1691 |
|
|
2016
Q1 | $8K | Buy |
+990
| New | +$9.74K | ﹤0.01% | 1183 |
|
|
2015
Q1 | – | Sell |
-3,256
| Closed | -$26K | – | 2102 |
|
|
2014
Q4 | $26K | Sell |
3,256
-1,474
| -31% | -$9.43K | ﹤0.01% | 1663 |
|
|
2014
Q3 | $23K | Buy |
+4,730
| New | +$24.7K | ﹤0.01% | 1702 |
|
Other funds holding PACB
AIM
MA
EDRH
NAMA
